For treatment of paucibacillary leprosy drugs used are –
**Core Concept**
Paucibacillary leprosy is a type of leprosy characterized by a low bacterial load, typically affecting a small number of nerves and skin lesions. The treatment for paucibacillary leprosy involves a combination of antibiotics to eliminate the bacteria and reduce the risk of complications.
**Why the Correct Answer is Right**
The recommended treatment for paucibacillary leprosy is a short-course multidrug therapy (MDT) regimen that consists of rifampicin and dapsone for 6 months. This regimen is effective in reducing the bacterial load, preventing the development of resistance, and minimizing the risk of complications such as nerve damage and disfigurement.
* Rifampicin is a powerful bactericidal agent that targets the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial death.
* Dapsone is a bacteriostatic agent that inhibits the synthesis of folic acid, which is essential for bacterial growth and survival.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify the correct combination of drugs for paucibacillary leprosy treatment.
**Option B:** This option is incorrect as it does not include rifampicin, which is a critical component of the treatment regimen.
**Option C:** This option is incorrect as it includes clofazimine, which is typically used in the treatment of multibacillary leprosy.
**Clinical Pearl / High-Yield Fact**
The World Health Organization (WHO) recommends a short-course MDT regimen for the treatment of paucibacillary leprosy, which consists of rifampicin and dapsone for 6 months. This regimen has been shown to be effective in reducing the bacterial load and preventing complications.
**Correct Answer:** C. Rifampicin and dapsone.